APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

Selected research

Market Structure

Global Gastrointestinal Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025191 pages

Choose your research edition.

Industry ResearchGastrointestinal Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Gastrointestinal Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.

Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.

Read the full market overview

In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.

Report Includes

This report provides an overview of the global Gastrointestinal market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastrointestinal and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastrointestinal revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gastrointestinal market size, projected growth trends, production technologies, key applications, and end-use industries.

Gastrointestinal Segment by Company

AstraZenec

Sanofi

Bayer

Pfizer

GlaxoSmithKline

Teva

Zeria（Tillotts）

Perrigo

Boehringer Ingelheim

Purdue Pharma

C.B. Fleet

Abbott

Jiangzhong

Xian-Janssen

Gastrointestinal Segment by Type

Prescription Gastrointestinal Drug

OTC Gastrointestinal Drug

Gastrointestinal Segment by Application

Chronic Gastritis

Functional Dyspepsia

Peptic Ulcer

Acute Gastroenteritis

Others

Gastrointestinal Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gastrointestinal in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gastrointestinal industry.

Chapter 3: Detailed analysis of Gastrointestinal companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinalrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Prescription Gastrointestinal Drug Table 3. Key Players of OTC Gastrointestinal Drug Table 4. Global Gastrointestinal Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Chronic Gastritis Table 6. Key Players of Functional Dyspepsia Table 7. Key Players of Peptic Ulcer Table 8. Key Players of Acute Gastroenteritis Table 9. Key Players of Others Table 10. Global Gastrointestinal Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Gastrointestinal Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Gastrointestinal Market Share by Region (2021-2026) Table 13. Global Gastrointestinal Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Gastrointestinal Market Share by Region (2027-2032) Table 15. Gastrointestinal Industry Trends Table 16. Gastrointestinal Industry Drivers Table 17. Gastrointestinal Industry Opportunities and Challenges Table 18. Gastrointestinal Industry Restraints Table 19. Global Gastrointestinal Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Gastrointestinal Revenue Market Share by Company (2021-2026) Table 21. Global Gastrointestinal Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Gastrointestinal Key Company Head Office and Area Served Table 23. Global Gastrointestinal Company, Product Type & Application Table 24. Global Gastrointestinal Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Gastrointestinal by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Gastrointestinal Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Gastrointestinal Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Gastrointestinal Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Gastrointestinal Revenue Market Share by Type (2021-2026) Table 31. Global Gastrointestinal Revenue Market Share by Type (2027-2032) Table 32. Global Gastrointestinal Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Gastrointestinal Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Gastrointestinal Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Gastrointestinal Revenue Market Share by Application (2021-2026) Table 36. Global Gastrointestinal Revenue Market Share by Application (2027-2032) Table 37. AstraZenec Company Information Table 38. AstraZenec Business Overview Table 39. AstraZenec Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AstraZenec Gastrointestinal Product Portfolio Table 41. AstraZenec Recent Development Table 42. Sanofi Company Information Table 43. Sanofi Business Overview Table 44. Sanofi Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Sanofi Gastrointestinal Product Portfolio Table 46. Sanofi Recent Development Table 47. Bayer Company Information Table 48. Bayer Business Overview Table 49. Bayer Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Bayer Gastrointestinal Product Portfolio Table 51. Bayer Recent Development Table 52. Pfizer Company Information Table 53. Pfizer Business Overview Table 54. Pfizer Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Pfizer Gastrointestinal Product Portfolio Table 56. Pfizer Recent Development Table 57. GlaxoSmithKline Company Information Table 58. GlaxoSmithKline Business Overview Table 59. GlaxoSmithKline Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. GlaxoSmithKline Gastrointestinal Product Portfolio Table 61. GlaxoSmithKline Recent Development Table 62. Teva Company Information Table 63. Teva Business Overview Table 64. Teva Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Teva Gastrointestinal Product Portfolio Table 66. Teva Recent Development Table 67. Zeria（Tillotts） Company Information Table 68. Zeria（Tillotts） Business Overview Table 69. Zeria（Tillotts） Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Zeria（Tillotts） Gastrointestinal Product Portfolio Table 71. Zeria（Tillotts） Recent Development Table 72. Perrigo Company Information Table 73. Perrigo Business Overview Table 74. Perrigo Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Perrigo Gastrointestinal Product Portfolio Table 76. Perrigo Recent Development Table 77. Boehringer Ingelheim Company Information Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Boehringer Ingelheim Gastrointestinal Product Portfolio Table 81. Boehringer Ingelheim Recent Development Table 82. Purdue Pharma Company Information Table 83. Purdue Pharma Business Overview Table 84. Purdue Pharma Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Purdue Pharma Gastrointestinal Product Portfolio Table 86. Purdue Pharma Recent Development Table 87. C.B. Fleet Company Information Table 88. C.B. Fleet Business Overview Table 89. C.B. Fleet Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. C.B. Fleet Gastrointestinal Product Portfolio Table 91. C.B. Fleet Recent Development Table 92. Abbott Company Information Table 93. Abbott Business Overview Table 94. Abbott Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Abbott Gastrointestinal Product Portfolio Table 96. Abbott Recent Development Table 97. Jiangzhong Company Information Table 98. Jiangzhong Business Overview Table 99. Jiangzhong Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Jiangzhong Gastrointestinal Product Portfolio Table 101. Jiangzhong Recent Development Table 102. Xian-Janssen Company Information Table 103. Xian-Janssen Business Overview Table 104. Xian-Janssen Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Xian-Janssen Gastrointestinal Product Portfolio Table 106. Xian-Janssen Recent Development Table 107. North America Gastrointestinal Market Size by Type (2021-2026) & (US$ Million) Table 108. North America Gastrointestinal Market Size by Type (2027-2032) & (US$ Million) Table 109. North America Gastrointestinal Market Size by Application (2021-2026) & (US$ Million) Table 110. North America Gastrointestinal Market Size by Application (2027-2032) & (US$ Million) Table 111. North America Gastrointestinal Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Gastrointestinal Market Size by Country (2021-2026) Table 113. North America Gastrointestinal Market Size by Country (2027-2032) Table 114. Europe Gastrointestinal Market Size by Type (2021-2026) & (US$ Million) Table 115. Europe Gastrointestinal Market Size by Type (2027-2032) & (US$ Million) Table 116. Europe Gastrointestinal Market Size by Application (2021-2026) & (US$ Million) Table 117. Europe Gastrointestinal Market Size by Application (2027-2032) & (US$ Million) Table 118. Europe Gastrointestinal Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Gastrointestinal Market Size by Country (2021-2026) Table 120. Europe Gastrointestinal Market Size by Country (2027-2032) Table 121. China Gastrointestinal Market Size by Type (2021-2026) & (US$ Million) Table 122. China Gastrointestinal Market Size by Type (2027-2032) & (US$ Million) Table 123. China Gastrointestinal Market Size by Application (2021-2026) & (US$ Million) Table 124. China Gastrointestinal Market Size by Application (2027-2032) & (US$ Million) Table 125. Asia Gastrointestinal Market Size by Type (2021-2026) & (US$ Million) Table 126. Asia Gastrointestinal Market Size by Type (2027-2032) & (US$ Million) Table 127. Asia Gastrointestinal Market Size by Application (2021-2026) & (US$ Million) Table 128. Asia Gastrointestinal Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Gastrointestinal Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Gastrointestinal Market Size by Country (2021-2026) Table 131. Asia Gastrointestinal Market Size by Country (2027-2032) Table 132. South America, Middle East & Africa Gastrointestinal Market Size by Type (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Gastrointestinal Market Size by Type (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Gastrointestinal Market Size by Application (2021-2026) & (US$ Million) Table 135. South America, Middle East & Africa Gastrointestinal Market Size by Application (2027-2032) & (US$ Million) Table 136. South America, Middle East & Africa Gastrointestinal Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. South America, Middle East & Africa Gastrointestinal Market Size by Country (2021-2026) Table 138. South America, Middle East & Africa Gastrointestinal Market Size by Country (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Gastrointestinal Product Image Figure 2. Global Gastrointestinal Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gastrointestinal Market Share by Type: 2025 VS 2032 Figure 4. Prescription Gastrointestinal Drug Image Figure 5. OTC Gastrointestinal Drug Image Figure 6. Global Gastrointestinal Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Gastrointestinal Market Share by Application: 2025 VS 2032 Figure 8. Chronic Gastritis Image Figure 9. Functional Dyspepsia Image Figure 10. Peptic Ulcer Image Figure 11. Acute Gastroenteritis Image Figure 12. Others Image Figure 13. Global Gastrointestinal Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 15. Global Gastrointestinal Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Gastrointestinal Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Gastrointestinal Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Gastrointestinal Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Gastrointestinal Revenue Market Share by Type (2021-2032) Figure 22. Global Gastrointestinal Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gastrointestinal Revenue Market Share by Application (2021-2032) Figure 24. North America Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 25. North America Gastrointestinal Market Share by Type (2021-2032) Figure 26. North America Gastrointestinal Market Share by Application (2021-2032) Figure 27. North America Gastrointestinal Market Share by Country (2021-2032) Figure 28. United States Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 29. Canada Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 31. Europe Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 32. Europe Gastrointestinal Market Share by Type (2021-2032) Figure 33. Europe Gastrointestinal Market Share by Application (2021-2032) Figure 34. Europe Gastrointestinal Market Share by Country (2021-2032) Figure 35. Germany Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 36. France Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 38. Italy Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 39. Russia Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 41. China Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 42. China Gastrointestinal Market Share by Type (2021-2032) Figure 43. China Gastrointestinal Market Share by Application (2021-2032) Figure 44. Asia Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 45. Asia Gastrointestinal Market Share by Type (2021-2032) Figure 46. Asia Gastrointestinal Market Share by Application (2021-2032) Figure 47. Asia Gastrointestinal Market Share by Country (2021-2032) Figure 48. Japan Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 52. India Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 53. Australia Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Gastrointestinal Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Gastrointestinal Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Gastrointestinal Market Share by Country (2021-2032) Figure 58. Brazil Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 63. UAE Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 65. Chile Gastrointestinal Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Gastrointestinal Drug
  • OTC Gastrointestinal Drug
Applications
  • Chronic Gastritis
  • Functional Dyspepsia
  • Peptic Ulcer
  • Acute Gastroenteritis
  • Others
Companies covered
  • AstraZenec
  • Sanofi
  • Bayer
  • Pfizer
  • GlaxoSmithKline
  • Teva
  • Zeria（Tillotts）
  • Perrigo
  • Boehringer Ingelheim
  • Purdue Pharma
  • C.B. Fleet
  • Abbott
  • Jiangzhong
  • Xian-Janssen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gastrointestinal Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Prescription Gastrointestinal Drug
  5. 1.2.3 OTC Gastrointestinal Drug
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Gastrointestinal Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Chronic Gastritis
  9. 1.3.3 Functional Dyspepsia
  10. 1.3.4 Peptic Ulcer
  11. 1.3.5 Acute Gastroenteritis
  12. 1.3.6 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Gastrointestinal Growth Trends by Region
  15. 1.5.1 Global Gastrointestinal Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Gastrointestinal Market Size by Region (2021-2026)
  17. 1.5.3 Gastrointestinal Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Gastrointestinal Market Dynamics
  1. 2.1 Gastrointestinal Industry Trends
  2. 2.2 Gastrointestinal Industry Drivers
  3. 2.3 Gastrointestinal Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gastrointestinal Revenue by Company (2021-2026)
  2. 3.2 Global Gastrointestinal Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gastrointestinal Key Company Head office and Area Served
  4. 3.4 Global Gastrointestinal Company, Product Type & Application
  5. 3.5 Global Gastrointestinal Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gastrointestinal Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gastrointestinal Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gastrointestinal Tier 1, Tier 2, and Tier 3
4 Gastrointestinal Market by Type
  1. 4.1 Global Gastrointestinal Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gastrointestinal Market Size by Type (2021-2032)
  3. 4.3 Global Gastrointestinal Market Size Share by Type (2021-2032)
5 Gastrointestinal Market by Application
  1. 5.1 Global Gastrointestinal Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gastrointestinal Market Size by Application (2021-2032)
  3. 5.3 Global Gastrointestinal Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AstraZenec
  2. 6.1.1 AstraZenec Company Information
  3. 6.1.2 AstraZenec Business Overview
  4. 6.1.3 AstraZenec Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AstraZenec Gastrointestinal Product Portfolio
  6. 6.1.5 AstraZenec Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sanofi Gastrointestinal Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bayer Gastrointestinal Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Gastrointestinal Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKline Gastrointestinal Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Teva
  32. 6.6.1 Teva Company Information
  33. 6.6.2 Teva Business Overview
  34. 6.6.3 Teva Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Teva Gastrointestinal Product Portfolio
  36. 6.6.5 Teva Recent Developments
  37. 6.7 Zeria（Tillotts）
  38. 6.7.1 Zeria（Tillotts） Company Information
  39. 6.7.2 Zeria（Tillotts） Business Overview
  40. 6.7.3 Zeria（Tillotts） Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Zeria（Tillotts） Gastrointestinal Product Portfolio
  42. 6.7.5 Zeria（Tillotts） Recent Developments
  43. 6.8 Perrigo
  44. 6.8.1 Perrigo Company Information
  45. 6.8.2 Perrigo Business Overview
  46. 6.8.3 Perrigo Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Perrigo Gastrointestinal Product Portfolio
  48. 6.8.5 Perrigo Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Gastrointestinal Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
  55. 6.10 Purdue Pharma
  56. 6.10.1 Purdue Pharma Company Information
  57. 6.10.2 Purdue Pharma Business Overview
  58. 6.10.3 Purdue Pharma Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Purdue Pharma Gastrointestinal Product Portfolio
  60. 6.10.5 Purdue Pharma Recent Developments
  61. 6.11 C.B. Fleet
  62. 6.11.1 C.B. Fleet Company Information
  63. 6.11.2 C.B. Fleet Business Overview
  64. 6.11.3 C.B. Fleet Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 C.B. Fleet Gastrointestinal Product Portfolio
  66. 6.11.5 C.B. Fleet Recent Developments
  67. 6.12 Abbott
  68. 6.12.1 Abbott Company Information
  69. 6.12.2 Abbott Business Overview
  70. 6.12.3 Abbott Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Abbott Gastrointestinal Product Portfolio
  72. 6.12.5 Abbott Recent Developments
  73. 6.13 Jiangzhong
  74. 6.13.1 Jiangzhong Company Information
  75. 6.13.2 Jiangzhong Business Overview
  76. 6.13.3 Jiangzhong Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Jiangzhong Gastrointestinal Product Portfolio
  78. 6.13.5 Jiangzhong Recent Developments
  79. 6.14 Xian-Janssen
  80. 6.14.1 Xian-Janssen Company Information
  81. 6.14.2 Xian-Janssen Business Overview
  82. 6.14.3 Xian-Janssen Gastrointestinal Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Xian-Janssen Gastrointestinal Product Portfolio
  84. 6.14.5 Xian-Janssen Recent Developments
7 North America
  1. 7.1 North America Gastrointestinal Market Size (2021-2032)
  2. 7.2 North America Gastrointestinal Market Size by Type
  3. 7.2.1 North America Gastrointestinal Market Size by Type (2021-2026)
  4. 7.2.2 North America Gastrointestinal Market Size by Type (2027-2032)
  5. 7.2.3 North America Gastrointestinal Market Share by Type (2021-2032)
  6. 7.3 North America Gastrointestinal Market Size by Application
  7. 7.3.1 North America Gastrointestinal Market Size by Application (2021-2026)
  8. 7.3.2 North America Gastrointestinal Market Size by Application (2027-2032)
  9. 7.3.3 North America Gastrointestinal Market Share by Application (2021-2032)
  10. 7.4 North America Gastrointestinal Market Size by Country
  11. 7.4.1 North America Gastrointestinal Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gastrointestinal Market Size by Country (2021-2026)
  13. 7.4.3 North America Gastrointestinal Market Size by Country (2027-2032)
  14. 7.4.4 North America Gastrointestinal Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gastrointestinal Market Size (2021-2032)
  2. 8.2 Europe Gastrointestinal Market Size by Type
  3. 8.2.1 Europe Gastrointestinal Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gastrointestinal Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gastrointestinal Market Share by Type (2021-2032)
  6. 8.3 Europe Gastrointestinal Market Size by Application
  7. 8.3.1 Europe Gastrointestinal Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gastrointestinal Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gastrointestinal Market Share by Application (2021-2032)
  10. 8.4 Europe Gastrointestinal Market Size by Country
  11. 8.4.1 Europe Gastrointestinal Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gastrointestinal Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gastrointestinal Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gastrointestinal Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gastrointestinal Market Size (2021-2032)
  2. 9.2 China Gastrointestinal Market Size by Type
  3. 9.2.1 China Gastrointestinal Market Size by Type (2021-2026)
  4. 9.2.2 China Gastrointestinal Market Size by Type (2027-2032)
  5. 9.2.3 China Gastrointestinal Market Share by Type (2021-2032)
  6. 9.3 China Gastrointestinal Market Size by Application
  7. 9.3.1 China Gastrointestinal Market Size by Application (2021-2026)
  8. 9.3.2 China Gastrointestinal Market Size by Application (2027-2032)
  9. 9.3.3 China Gastrointestinal Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gastrointestinal Market Size (2021-2032)
  2. 10.2 Asia Gastrointestinal Market Size by Type
  3. 10.2.1 Asia Gastrointestinal Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gastrointestinal Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gastrointestinal Market Share by Type (2021-2032)
  6. 10.3 Asia Gastrointestinal Market Size by Application
  7. 10.3.1 Asia Gastrointestinal Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gastrointestinal Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gastrointestinal Market Share by Application (2021-2032)
  10. 10.4 Asia Gastrointestinal Market Size by Country
  11. 10.4.1 Asia Gastrointestinal Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gastrointestinal Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gastrointestinal Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gastrointestinal Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gastrointestinal Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gastrointestinal Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gastrointestinal Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gastrointestinal Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gastrointestinal Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gastrointestinal Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gastrointestinal Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gastrointestinal Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gastrointestinal Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gastrointestinal Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gastrointestinal Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gastrointestinal Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gastrointestinal Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gastrointestinal Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst